FDA Clears First of Robotic Exoskeleton for Multiple Sclerosis

The wearable EksoNR robotic exoskeleton is the first FDA-cleared exoskeleton for use in the rehabilitation of patients with multiple sclerosis.
FDA Approvals

Leave a Reply

Your email address will not be published. Required fields are marked *